0000899243-22-000877.txt : 20220105 0000899243-22-000877.hdr.sgml : 20220105 20220105160536 ACCESSION NUMBER: 0000899243-22-000877 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maimon Yossi CENTRAL INDEX KEY: 0001385115 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39279 FILM NUMBER: 22511115 MAIL ADDRESS: STREET 1: C/O PROTALIX BIOTHERAPEUTICS, INC. STREET 2: 2 SNUNIT ST, SCIENCE PARK, POB 455 CITY: CARMIEL STATE: L3 ZIP: 20100 FORMER NAME: FORMER CONFORMED NAME: Yossi Maimon DATE OF NAME CHANGE: 20070104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001797336 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823578375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: (857) 444-0553 MAIL ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-03 0 0001797336 Ayala Pharmaceuticals, Inc. AYLA 0001385115 Maimon Yossi OPPENHEIMER 4 REHOVOT L3 7670104 ISRAEL 0 1 0 0 CFO, Secretary & Treasurer Stock Option 9.105 2022-01-03 4 A 0 31950 0.00 A 2032-01-02 Common Stock 31950 31950 D This option vests and becomes exercisable in sixteen substantially equal quarterly installments from the grants date, such that the option shall be fully vested on January 3, 2026. /s/ Roni Mamluk, Ph.D., Attorney-in-Fact for Yossi Maimon 2022-01-05